Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
43,354
Total Claims
$3.1M
Drug Cost
1,282
Beneficiaries
$2,413
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-98%
Opioid rate vs peers
0.1% vs 2.6% avg
+126%
Cost per patient vs peers
$2,413 vs $1,068 avg
+31%
Brand preference vs peers
11.8% vs 9.0% avg
Opioid Prescribing
0.1%
Opioid Rate
27
Opioid Claims
$294
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 5,084 claims · $2.2M
Generic: 38,037 claims · $930K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 54 | $309K |
| Apixaban | 880 | $246K |
| Bictegrav/Emtricit/Tenofov Ala | 36 | $147K |
| Aripiprazole Lauroxil | 44 | $109K |
| Rivaroxaban | 332 | $100K |
| Deutetrabenazine | 21 | $87K |
| Paliperidone Palmitate | 24 | $70K |
| Dulaglutide | 79 | $67K |
| Empagliflozin | 196 | $66K |
| Collagenase Clostridium Hist. | 103 | $62K |
| Insulin Glargine,hum.Rec.Anlog | 233 | $47K |
| Darunavir | 36 | $38K |
| Atorvastatin Calcium | 2,913 | $36K |
| Insulin Aspart | 206 | $36K |
| Rifaximin | 24 | $35K |
Prescribing Profile
Patient Profile
68
Avg Age
43%
Female
2.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data